A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma

Kras-driven lung adenocarcinoma (LUAD) is the most common lung cancer. A significant fraction of patients with Kras-driven LUAD respond to immunotherapy, but mechanistic studies of immune responses against LUAD have been limited because of a lack of immunotherapy-responsive models. We report the dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, Brittany, Connolly, Kelli A., Cui, Can, Fagerberg, Eric, Mariuzza, Dylan L., Hornick, Noah I., Foster, Gena G., William, Ivana, Cheung, Julie F., Joshi, Nikhil S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500377/
https://www.ncbi.nlm.nih.gov/pubmed/34632444
http://dx.doi.org/10.1016/j.crmeth.2021.100080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500377/
https://www.ncbi.nlm.nih.gov/pubmed/34632444
http://dx.doi.org/10.1016/j.crmeth.2021.100080

Ejemplares similares